Marked Chart Marked Chart Closed

The Marked Chart Wire · Series of events

Series of events · Oklo

Oklo advances nuclear plans with DOE support and earnings

Oklo secured a DOE initiative, beat earnings estimates, and received clearance for reactor testing.

3 eventsOct 13 to Nov 11OKLO-4.4%

Updated

The flow in 3 points

  1. Oklo selected for DOE initiative to produce medical isotopes
  2. Quarterly revenue of $1.86 million beat estimates by 68 percent
  3. DOE cleared unrestricted research at Groves-1 reactor

What happened, in order

Times are Eastern
  1. Where it began

    DOE initiative pick

    Oklo was selected for the DOE Nuclear Energy Launch Pad initiative to build a Texas facility for medical isotopes.

  2. Earnings beat

    Oklo reported quarterly revenue of $1.86 million, beating estimates by 68 percent, with an EPS of -$0.22.

    Read the story
  3. Latest

    Reactor clearance

    The DOE cleared Oklo to conduct unrestricted research and testing at its Groves-1 reactor, which hit first criticality in August 2026.

    Read the story

How they connect

Oklo was first selected for a DOE initiative to produce medical isotopes, followed by a quarterly earnings report that beat estimates. The company then received DOE clearance for unrestricted research at its Groves-1 reactor.

The stocks in this series

  1. OKLO-4.4%Oklo$20.84

Prices from Based on Thu, Nov 19 close · Opens Fri 9:30 AM ET. Each tile opens the stock's chart and news.

A series is a short summary of connected news, for learning. Not verified and not advice. Check the full stories before you act.